Related Experiment Video
Updated: Jun 19, 2026
04:41
Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas
Published on: July 25, 2025
MORPHINE HYPERGLYCEMIA IN DOGS WITH EXPERIMENTAL PANCREATIC DEFICIENCY
1Department of Physiology and Pharmacology of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Morphine sulfate significantly elevates blood sugar in dogs with pancreatic deficiency, indicating a potential prediabetic state. This suggests the morphine test could detect weakened carbohydrate metabolism in humans.
Area of Science:
- Endocrinology
- Pharmacology
- Metabolic Research
Background:
- Pancreatic deficiency can lead to a prediabetic state with impaired carbohydrate metabolism.
- Morphine sulfate's effect on blood glucose levels is not fully understood in compromised metabolic conditions.
Purpose of the Study:
- To investigate the impact of morphine sulfate on glycemia in dogs with induced pancreatic deficiency.
- To evaluate the potential of the morphine test for identifying weakened carbohydrate metabolism.
Main Methods:
- Subcutaneous injection of morphine sulfate (1-2 mg/kg) in dogs with pancreatic deficiency and normal dogs.
- Monitoring of blood glucose (glycemia) levels post-injection.
- Comparison of glycemic response between the two groups.
Main Results:
- Dogs with pancreatic deficiency exhibited a fourfold greater increase in glycemia compared to normal dogs after morphine sulfate administration.
- This heightened glycemic response suggests a significantly altered carbohydrate metabolism.
Conclusions:
- Morphine sulfate elicits a disproportionately larger glycemic response in a prediabetic state (pancreatic deficiency).
- The morphine test may serve as a valuable, safe tool for detecting impaired carbohydrate metabolism in humans using micro blood sugar determination methods.
- Individual organism response to drugs can vary significantly based on underlying pathological conditions.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...